Stimate nasal and Wellcovorin

• Generic Name: desmopressin
• Dosage Forms: nasal spray
• Other Brand Names: DDAVP nasal, DDAVP Rhinal Tube, Noctiva, Stimate, DDAVP, Nocdurna

Stimate is a man-made form of a hormone that occurs naturally in the pituitary gland. This hormone affects blood pressure, kidney function, and regulating how the body uses water.

Stimate is used to treat central cranial diabetes insipidus, and increased thirst and urination caused by head surgery or head trauma.

Stimate is used to treat bleeding episodes in people with hemophilia A or von Willebrand's disease Type I.

Noctiva is used to treat excessive night-time urination in adults who are at least 50 years old. Noctiva should not be used to treat night-time bedwetting.

Stimate may also be used for purposes not listed in this medication guide.

• Generic Name: leucovorin
• Dosage Forms: n.a.
• Other Brand Names: Wellcovorin

Antidote for unintentional overdosage of methotrexate (e.g., resulting from impaired elimination) and other folic acid antagonists (e.g., pyrimethamine, trimethoprim).

IV rescue therapy after high-dose methotrexate regimen (to control duration of exposure of sensitive cells to methotrexate) in the treatment of osteosarcoma (designated an orphan drug by FDA for this use).

Prevention of hematologic toxicity associated with pyrimethamine, trimethoprim, or trimetrexate therapy.

IV treatment of folate deficient megaloblastic anemias (e.g., serum folate concentration <0.002 mcg/mL) of infancy, pregnancy, sprue, and nutritional deficiencies when oral folic acid therapy is not feasible. No advantage over folic acid injection since ability to convert folic acid to tetrahydrofolic acid (THF) is not impaired in these anemias.

Effective in the treatment of megaloblastic anemia resulting from congenital dihydrofolate reductase deficiency.

Not effective in the treatment of pernicious anemia and other megaloblastic anemias secondary to lack of vitamin B12; avoid such use. (See Contraindications under Cautions.)

Adjunct to fluorouracil to prolong survival in the palliative treatment of advanced colorectal cancer (designated an orphan drug by FDA for this use).

First-line therapy for management of advanced colorectal cancer in a combination regimen consisting of fluorouracil, leucovorin, and either irinotecan or oxaliplatin.